Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.

by | May 15, 2017 | Journal Club, landmark

Journal Club Summary   Methodology Score: 3/5                    Usefulness Score:  3.5/5 Nijssen EC, et al Lancet. 2017 Feb 20. [Epub ahead of print]   Abstract Link  This prospective, open-label, single centre, randomized trial of 660 patients found no hydration...